,i #aaith ,,congress #b;d ,session ,h4 ,r4 #hcci ,,in ,,the ,,house ,,of ,,representatives ,april #af1 #bjbf,ms4 ,matsui 7for herself1 ,mr4 ,crenshaw1 ,ms4 ,schrier1 and ,mrs4 ,hinson7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to enhance drug manufacturing amount information reporting1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,drug ,origin ,transparency ,act of #bjbf4 #b4 ,enhanced drug manufacturing amount information reporting 7a7 ,in general ,section #eaj7;j77#c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj7;j77#c77 is amended-- 7#a7 in subparagraph 7,a71 by adding or 7#b7 after paragraph 7#a72 and 7#b7 by adding at the end the following3 7,c7 ,each report submitted pursuant to subparagraph 7,a7 with respect to a drug shall-- 7i7 include additional information as may be specified by the ,secretary in regulation or guidance regarding the supply chain for such drug1 such as-- 7,i7 the identity of the respective suppliers of each active pharmaceutical ingredient1 active pharmaceutical ingredient intermediate1 and in-process material used in such manufacture1 preparation1 propagation1 compounding1 or processing of the drug2 and 7,,ii7 the respective amounts of such drug that were manufactured1 prepared1 propagated1 compounded1 or processed using an active pharmaceutical ingredient1 active pharmaceutical ingredient intermediate1 and in-process material from each such identified supplier2 and 7ii7 be submitted more frequently than annually1 in accordance with a reporting schedule as may be specified by the ,secretary in such regulation or guidance1 but not more frequently than #d times per year4 7,d7 ,any additional information specified in regulation or guidance pursuant to subparagraph 7,c7 shall be a required element of reports under this paragraph not earlier than #f months after the date on which such regulation or guidance is issued in final form 7and in no event shall the absence of any regulation or guidance issued under subparagraph 7,c7 affect the requirement to report as described in subparagraph 7,a774 4 7b7 ,conforming amendment ,section #eaj7;j77#c77;,b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #eaj7;j77#c77;,b77 is amended by striking subparagraph 7,a7 and inserting this paragraph4 #c4 ,require drug labeling to include original manufacturer and supply chain information ,section #ejb of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb7 is amended-- 7#a7 in paragraph 7b7-- 7,a7 by striking 7b7 ,if in a package and inserting 7b77#a7 ,if in a package2 7,b7 by striking a label containing 7#a7 the name and place and inserting a label containing-- 7,a7 the name and place 2 7,c7 by striking or distributor2 and 7#b7 an accurate statement and inserting or distributor2 and 7,b7 an accurate statement 2 7,d7 by striking under clause 7#b7 of this paragraph and inserting under this clause2 and 7,e7 by inserting at the end the following3 7#b7 7,a7 ,subject to clause 7,c71 if it is a drug1 including an active pharmaceutical ingredient1 unless it bears a label containing the name and place of business1 and unique facility identifier of the original manufacturer of such drug or active pharmaceutical ingredient1 except that the ,secretary may provide1 by regulation1 for reasonable variations in the implementation of such labeling requirements4 7,b7 ,subject to clause 7,c71 if it is a drug that is an active pharmaceutical ingredient1 unless any accompanying certificate of analysis contains the name and place of business1 and unique facility identifier of the original manufacturer of the active pharmaceutical ingredient4 7,c7 ,the ,secretary may provide1 by regulation1 for reasonable variations in the implementation of labeling requirements specified in this subparagraph4 2 and 7#b7 by inserting after paragraph 7c7 the following3 7d7 7#a7 ,subject to subparagraph 7#b71 if it is a drug1 including an active pharmaceutical ingredient1 unless it bears labeling containing the name and place of business of-- 7,a7 the original manufacturer of each active pharmaceutical ingredient2 7,b7 each manufacturer1 if different from the original manufacturer2 and 7,c7 the packer or distributor1 if any4 7#b7 ,the ,secretary may provide1 by regulation1 for reasonable variations or an alternative placement for the labeling requirements specified in subparagraph 7#a71 including by electronic means4 4